Disproportionality Analysis of Lenvatinib‐Caused Gastrointestinal Perforation in Cancer Patients: A Pharmacovigilance Analysis Based on the US Food and Drug Administration Adverse Event Reporting System

医学 胃肠道穿孔 穿孔 伦瓦提尼 不利影响 胃肠道癌 内科学 肿瘤科 不良事件报告系统 胃肠道 癌症 结直肠癌 外科 胃肠病学 腹膜炎 材料科学 冶金 冲孔 甲状腺癌
作者
Jianxing Zhou,Zipeng Wei,You Zheng,Helin Xie,Wanxia Cao,Xin-Ying Cai,Jialin Huang,Xuemei Wu
出处
期刊:The Journal of Clinical Pharmacology [Wiley]
卷期号:63 (10): 1133-1140 被引量:2
标识
DOI:10.1002/jcph.2312
摘要

Lenvatinib is a medication that targets multiple tyrosine kinases and is commonly used to treat various types of cancer. With its frequent usage, monitoring and assessing its potential adverse effects has become crucial. This study utilizes the US Food and Drug Administration Adverse Event Reporting System (FAERS) database to analyze the possible link between lenvatinib and gastrointestinal perforation. FAERS was used to analyze adverse drug reactions (ADRs) linked with lenvatinib from the first quarter of 2015 to the last quarter of 2022. The association between lenvatinib and gastrointestinal perforation was evaluated using disproportionality analyses. This study included 464 patients who developed gastrointestinal perforation after using lenvatinib. Perforation involved the entire digestive tract, with the colon among the most commonly affected perforation sites, and previously undetected esophageal perforation was frequently observed. Patients with uterine and liver cancer were at a higher risk of developing gastrointestinal perforation; patients with liver cancer experienced a shorter onset time, whereas patients with endometrial cancer had a slower onset time. Middle-aged and elderly patients exhibited a higher propensity for developing gastrointestinal perforation than younger adults. Patients with gastrointestinal perforation were found to have a significantly higher mortality rate than patients without gastrointestinal perforation. This study has identified several gastrointestinal perforation events not included in the drug instructions. It has also described the perforation site and clinical characteristics based on various types of cancer. These results could provide valuable insights for developing safer and more effective regulatory strategies concerning the use of lenvatinib.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
方方发布了新的文献求助10
刚刚
苯环羟基发布了新的文献求助10
刚刚
1秒前
无奈若雁完成签到,获得积分10
1秒前
Leonardi应助笑看人生采纳,获得400
1秒前
斯文败类应助光崽是谁采纳,获得10
1秒前
zhao完成签到,获得积分10
1秒前
香蕉觅云应助rapamycin采纳,获得10
2秒前
2秒前
在水一方应助complexshao采纳,获得10
2秒前
高挑的涛发布了新的文献求助10
2秒前
CMCM发布了新的文献求助30
2秒前
烟花应助ured采纳,获得10
2秒前
dlm发布了新的文献求助10
2秒前
3秒前
CodeCraft应助丁娜采纳,获得10
4秒前
榴下晨光发布了新的文献求助10
4秒前
4秒前
沐子发布了新的文献求助10
5秒前
wanci应助等风的人采纳,获得10
5秒前
Foch完成签到,获得积分10
6秒前
6秒前
LX发布了新的文献求助10
6秒前
lanshuitai发布了新的文献求助10
6秒前
7秒前
研友_LwbeX8完成签到,获得积分10
7秒前
Jcer发布了新的文献求助10
7秒前
7秒前
8秒前
9秒前
10秒前
10秒前
11秒前
ws发布了新的文献求助10
11秒前
甜甜的半仙完成签到 ,获得积分10
11秒前
等风的人完成签到,获得积分10
11秒前
慕青应助钟可可采纳,获得10
11秒前
12秒前
12秒前
方方完成签到,获得积分10
13秒前
高分求助中
The ACS Guide to Scholarly Communication 2500
Microlepidoptera Palaearctica, Volumes 1 and 3 - 13 (12-Volume Set) [German] 1122
The Data Economy: Tools and Applications 1000
Diamonds: Properties, Synthesis and Applications 800
PraxisRatgeber Mantiden., faszinierende Lauerjäger. – Buch gebraucht kaufen 700
Mantiden - Faszinierende Lauerjäger – Buch gebraucht kaufen 700
Ожившие листья и блуждающие цветы. Практическое руководство по содержанию богомолов [Alive leaves and wandering flowers. A practical guide for keeping praying mantises] 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3095922
求助须知:如何正确求助?哪些是违规求助? 2747787
关于积分的说明 7596792
捐赠科研通 2399425
什么是DOI,文献DOI怎么找? 1273033
科研通“疑难数据库(出版商)”最低求助积分说明 615515
版权声明 598948